Die & Mould Industry

The average Swiss Die & Mould Industry company is valued at 3.5 - 5.0× EBITDA on a statutory (tax-based) basis and 4.5 - 7.0× EBITDA in actual deal transactions. The spread between statutory and deal multiples represents a key arbitrage opportunity for informed buyers. The current market trend is stable, with an arbitrage gap rated as medium. Actual valuations depend heavily on recurring revenue share, customer diversification, management depth, and equipment modernity.

Key valuation drivers include: Micron-level precision and surface quality unmatched by most international competitors; EROWA's global standard-setting automation systems for mould-making originated in Switzerland. Factors that can compress valuations include: High cost structure — Swiss moulds cost 30-50% more than Portuguese, Turkish, or Chinese alternatives; Long lead times of 12-20 weeks for complex moulds vs. 6-10 weeks from Asian competitors. Deal multiples typically range from 4.5 - 7.0× EBITDA, but actual prices vary significantly based on customer concentration, management quality, revenue predictability, and geographic reach within Switzerland's 26 cantons.

Approximately ~950 companies operate in Switzerland's Die & Mould Industry sector. Active firms in die and mould manufacturing in Switzerland (BFS STATENT 2022) The sector employs ~12,500 people and represents a market of CHF 2.8B. Company counts have been evolving due to consolidation trends and succession-driven market exits across Swiss SME sectors.

The Swiss die and mould sector faces one of the most acute succession challenges in the entire MEM industry, with an estimated 14% of firms actively seeking ownership transitions. Mould-making is quintessentially a master craftsman's trade, where decades of experience in material behavior, process optimization, and customer-specific know-how create enormous tacit knowledge that is extremely difficult to transfer. Many of Switzerland's finest mould shops were established in the 1960s-1970s by master tool-makers who are now 65-75 years old. The small average firm size (<15 employees) makes profe...

The 4 key trends shaping Swiss Die & Mould Industry are: (1) Hybrid Manufacturing: Additive Meets Conventional; (2) Medtech Moulds: Growth Engine; (3) Digitalization and Simulation-Driven Design; (4) Sustainability and Circular Economy Moulds. Swiss mould-makers are increasingly adopting hybrid manufacturing approaches that combine traditional CNC milling and EDM with metal 3D printing for mould inserts. Conformal cooling channels produced ... These trends directly impact company valuations and M&A activity in the sector.

The principal acquisition risks are: (1) Chinese and Portuguese mould-makers closing the quality gap while maintaining 40-60% cost advantage; (2) 3D printing of end-use parts potentially reducing demand for injection moulds in some segments; (3) Automotive OEMs reducing model variety and consolidating mould suppliers. Buyers should conduct thorough due diligence on customer concentration, regulatory compliance, and key-person dependencies. Deal multiples of 4.5 - 7.0× EBITDA may be discounted for firms with elevated risk profiles.

The typical cost breakdown for a Swiss Die & Mould Industry firm is: Raw Materials (tool steel, carbide, copper): 22%, Personnel Costs: 38%, Equipment Depreciation (CNC, EDM, 3D): 12%, Software & CAE Licenses: 4%, Energy & Utilities: 3%, Other Operating Costs: 14%, Profit Margin (EBITDA): 7%. Based on Swiss mould-making industry averages (VSWF/Swissmem Survey 2024). Personnel costs dominate due to high proportion of skilled labor. Firms with own IP/standard mould bases may show different distributions. These benchmarks are important for buyers assessing operational efficiency and margin improvement potential post-acquisition.

Switzerland's main Die & Mould Industry clusters are: (1) Eastern Switzerland (TG, SH, SG); (2) Aargau / Mittelland (AG, SO, BL); (3) Central Switzerland (LU, ZG); (4) Zurich / Winterthur (ZH). Major mould-making cluster centered around Schöttli (Diessenhofen), Fostag (Stein am Rhein), and Priamus (Schaffhausen). Strong specialization in medi... Regional concentration affects valuations, as companies in established clusters benefit from supplier ecosystems, specialized talent pools, and industry networks.